|
Volumn 24, Issue 5, 2008, Pages 457-460
|
Anti-tumor immune responses of nanoemulsion-encapsulated MHS vaccine
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
GAMMA INTERFERON;
HEAT SHOCK PROTEIN 70;
HYBRID PROTEIN;
MAGEA1 PROTEIN, HUMAN;
TUMOR ANTIGEN;
TUMOR PROTEIN;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
C57BL MOUSE;
CD4+ T LYMPHOCYTE;
CYTOTOXIC T LYMPHOCYTE;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EXPERIMENTAL MELANOMA;
IMMUNIZATION;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
MALE;
METHODOLOGY;
MOUSE;
TUMOR CELL LINE;
ANIMALS;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
CD4-POSITIVE T-LYMPHOCYTES;
CELL LINE, TUMOR;
DRUG DELIVERY SYSTEMS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HSP70 HEAT-SHOCK PROTEINS;
IMMUNIZATION;
INTERFERON-GAMMA;
LYMPHOCYTE ACTIVATION;
MALE;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
NEOPLASM PROTEINS;
RECOMBINANT FUSION PROTEINS;
T-LYMPHOCYTES, CYTOTOXIC;
|
EID: 77951641628
PISSN: 10078738
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|